Pharma

Your Article Summary

See Latest Articles

Par pharmaceutical wins on invalidity in ultram er litigation
Par Pharmaceutical, 08/17/09

Par Pharmaceutical Companies, Inc. announced that the U.S. District Court for the District of Delaware has ruled in favor of Par in its challenge of Purdue's patents relating to extended–release tramadol, which are listed in the Orange Book for Ortho–McNeil's Ultram ER product. Par earlier announced that it had filed an ANDA seeking marketing approval for generic extended–release tramadol, and that it was the first–filed ANDA with respect to the Ultram ER product.

Today in Popular Press...keeping you current

Receive free subspecialty "5-minute updates" via email

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

 See all of Popular Press